FYERS
Aarey Drugs & Pharmaceuticals102.37
+0.24 (+0.23%)

Aarey Drugs & Pharmaceuticals Share Price

102.37+0.24 (+0.23%)
+31.92% past 1 Year

Corporate filings & documents

Announcements

Disclosure Under Regulation 30of SEBI(Listing Obligation And Disclosure Requirement ) Regulation 2015
1 week ago
Disclosure Under Regulation 30of SEBI(Listing Obligation And Disclosure Requirement ) Regulation 2015
1 week ago
Newspaper Publication
1 week ago
Newspaper Publication
1 week ago
Notice and Integrated Annual Report for 36TH Annual General Meeting of Company as required under Regulation 34(1)
1 week ago
Notice and Integrated Annual Report for 36TH Annual General Meeting of Company as required under Regulation 34(1)
1 week ago
Notice of 36th Annual General Meeting of the Company for the FY 2025-26
1 week ago
Notice of 36th Annual General Meeting of the Company for the FY 2025-26
1 week ago
Intimation of Book Closure
1 week ago
Intimation of Book Closure
1 week ago
As per attachment
2 weeks ago
As per attachment
2 weeks ago
As per the attachment
1 month ago
As per the attachment
1 month ago
As per Attachment
1 month ago
As per Attachment
1 month ago
Outcome of Board Meeting held on friday 14th August 2026
1 month ago
Outcome of Board Meeting held on friday 14th August 2026
1 month ago
Aarey Drugs & Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 inter alia to consider and approve This is to intimate that the meeting of the Board of Directors of the Company is scheduled to be held on Friday14th August 2026 to transact the following business:1. To consider and approve the Unaudited Financial Result along with Limited review Report for the quarterended 30th June 2026.2. Any other matter with consent of the Chairman.
1 month ago
Aarey Drugs & Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 inter alia to consider and approve This is to intimate that the meeting of the Board of Directors of the Company is scheduled to be held on Friday14th August 2026 to transact the following business:1. To consider and approve the Unaudited Financial Result along with Limited review Report for the quarterended 30th June 2026.2. Any other matter with consent of the Chairman.
1 month ago
Allotment of Equity Shares Pursuant to Conversion of Warrants
1 month ago
Allotment of Equity Shares Pursuant to Conversion of Warrants
1 month ago
Compliance Certificate under Reg 74(5) of Sebi(DP) Regulation 2018
2 months ago
Compliance Certificate under Reg 74(5) of Sebi(DP) Regulation 2018
2 months ago
Intimation for closure of trading window
2 months ago
Intimation for closure of trading window
2 months ago
As per Attachment
3 months ago
As per attachment
3 months ago
As per attachment
3 months ago
as per attachment
3 months ago
as per attachment
3 months ago
As per Attachment
3 months ago
As per Attachment
3 months ago
Outcome of Board Meeting held on Saturday 30th May 2026
3 months ago
Outcome of Board Meeting held on Saturday 30th May 2026
3 months ago
Aarey Drugs & Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2026 inter alia to consider and approve intimation regarding postponement and re-schedule of Board Meeting which was scheduled to be held on Friday 29th May 2026 is postponed and rescheduled on Saturday 30th May 2026
3 months ago
Aarey Drugs & Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2026 inter alia to consider and approve intimation regarding postponement and re-schedule of Board Meeting which was scheduled to be held on Friday 29th May 2026 is postponed and rescheduled on Saturday 30th May 2026
3 months ago
Aarey Drugs & Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2026 inter alia to consider and approve Pursuant to the provisions of Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 This is to inform you that a Meeting of the Board of Directors of the Company is scheduled to be held on Friday 29th May 2026 inter alia for the following:1. To consider and approve the Audited Financial Results along with the Auditors Report thereon of the Company for the quarter and financial year ended March 31 2026.2. To Consider any other matter with the permission of chair.
3 months ago
Aarey Drugs & Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2026 inter alia to consider and approve Pursuant to the provisions of Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 This is to inform you that a Meeting of the Board of Directors of the Company is scheduled to be held on Friday 29th May 2026 inter alia for the following:1. To consider and approve the Audited Financial Results along with the Auditors Report thereon of the Company for the quarter and financial year ended March 31 2026.2. To Consider any other matter with the permission of chair.
3 months ago
Certificate under Reg 74(5) of SEBI (Depositories and Participants) Regulations 2018
5 months ago
Certificate under Reg 74(5) of SEBI (Depositories and Participants) Regulations 2018
5 months ago
Intimation for closure of trading window
5 months ago
Intimation for closure of trading window
5 months ago
Newspaper Publication of the Unaudited Financial Results
7 months ago
Board Comments on the fine levied by the Exchange
7 months ago
Approval of Unaudited Financial Results for the quarter ended 31st December 2025
7 months ago
This is to inform you that the Board of Directors of the Company at its Meeting held today i.e. 11th February 2026 have passed the following resolution.1. The Board of Directors of the Company has considered and approved the Unaudited Financial Results for the quarter ended 31st December 2025 along with the Limited Review Report Report MD/CFO certification.*Company segment is single
7 months ago
Aarey Drugs & Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/02/2026 inter alia to consider and approve This is to intimate that the meeting of the Board of Directors of the Company is scheduled to be held on Wednesday11th February 2026 to transact the following business: 1. To consider and approve the Unaudited Financial Result along with Limited review Report for the quarter ended 31st December 2025.
7 months ago
Certificate under reg 74(5) of SEBI (Depositories and Participants) Regulations 2018
8 months ago
Intimation for Closure of Trading Window
8 months ago

Annual reports

FY 2023-24
FY 2022-23
FY 2021-22
FY 2020-21

Concalls & investor presentations

Empty box

No presentations found

Aarey Drugs & Pharmaceuticals Ltd Share Price Today

The Aarey Drugs & Pharmaceuticals Ltd share price today is ₹97.33. During the trading session, the Aarey Drugs & Pharmaceuticals Ltd share price opened at ₹94.10 and recorded an intraday high of ₹98.40 and a low of ₹94.10. Last closing price was ₹95.79. Over the past 52 weeks, the Aarey Drugs & Pharmaceuticals Ltd share price has ranged between ₹50.31 and ₹100.00. The current Aarey Drugs & Pharmaceuticals Ltd stock price reflects real-time market activity based on executed trades on the exchange.